12:00 AM
May 28, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Regorafenib regulatory update

Bayer submitted regulatory applications in the EU and U.S. for regorafenib to treat metastatic colorectal cancer (mCRC). Onyx Pharmaceuticals Inc. (NASDAQ:ONXX, South...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >